Versant Venture Capital Vi, L.P. Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

Versant Venture Capital Vi, L.P. is > 10% Shareholder of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 6.8 Million shares of GLUE, which is worth approximately $26.5 Million. The most recent transaction as insider was on Jun 28, 2021, when has been sold 6,515,869 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.8M

0% 3M change

0% 12M change

Total Value Held $26.5 Million

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 28 2021	BUY Conversion of derivative security	-	6,515,869 Added 48.94%	6,799,115 Common Stock

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

> 10% Shareholder

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OYST

Oyster Point Pharma, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

VVC